Month: April 2026
Industry
Pharmaceutical
Regulation
Learn the keypoint in two minutes: General Considerations for the Use of New Approach Methodologies in Drug Development
The central objective of the FDA’s draft guidance is to establish a rigorous validation framework, ensuring that New Approach Methodologies (NAMs) are reliable and fit-for-purpose for specific regulatory decisions. While “qualification” evaluates a tool’s general utility, validation...